Yuan‐Ping Pang

9.7k citations
187 papers · 7.8k indexed · h-index 50

Yuan‐Ping Pang

180 papers receiving 7.7k citations

Peers

Yuan‐Ping Pang
Comparison fields: 5 of 145
  • Pharmacology 3.0k
  • Computational Theory and Mathematics 1.9k
  • Molecular Biology 3.5k
  • Organic Chemistry 1.4k
  • Cellular and Molecular Neuroscience 892
Replace Paul H. Axelsen with:
Paul H. Axelsen United States
Terrone L. Rosenberry United States
Adrian Goldman Finland
Jeremy R. Greenwood United States
Robert A. Copeland United States
Paul R. Carlier United States
Ana Martı́nez Spain
Jonathan B. Baell Australia
Jason E. Gestwicki United States
Giulio Vistoli Italy
Yuan‐Ping Pang relative to Paul H. Axelsen United States Paul H. Axelsen's profile →
Citations per field
00.5×
Paul H. Axelsen · 1×
Citations per year

Countries citing papers authored by Yuan‐Ping Pang

Since Specialization
Citations

This map shows the geographic impact of Yuan‐Ping Pang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuan‐Ping Pang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuan‐Ping Pang more than expected).

Fields of papers citing papers by Yuan‐Ping Pang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuan‐Ping Pang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuan‐Ping Pang. The network helps show where Yuan‐Ping Pang may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Yuan‐Ping Pang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yuan‐Ping Pang Line = papers co-authored together Yuan‐Ping Pang links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20252
3 20248
4 20221
5 202117
6 20209
7 20187
8 201719
9 201318
10 201245
11 2011123
12 200938
13 200817
14 200712
15 200738
16 200769
17 20075
18 20045
19 200176
20 199924

About Yuan‐Ping Pang

Yuan‐Ping Pang is a scholar working on Pharmacology, Computational Theory and Mathematics and Cellular and Molecular Neuroscience, having authored 187 papers that have together received 7.8k indexed citations. Recurring topics across this work include Cholinesterase and Neurodegenerative Diseases (72 papers), Computational Drug Discovery Methods (42 papers), Neuroscience and Neuropharmacology Research (22 papers), Protein Structure and Dynamics (19 papers), Chemical Synthesis and Analysis (16 papers), Chemical synthesis and alkaloids (15 papers), Alzheimer's disease research and treatments (14 papers) and Nicotinic Acetylcholine Receptors Study (14 papers). The work is most often cited by research in Pharmacology (3.0k citations), Computational Theory and Mathematics (1.9k citations) and Molecular Biology (3.5k citations). Yuan‐Ping Pang has collaborated with scholars based in United States, Hong Kong and China. Frequent co-authors include Yifan Han, Stephen Brimijoin, Jamal El Yazal, Paul R. Carlier, Alan P. Kozikowski, Andrés F. Oberhauser, Piotr E. Marszałek, Julio M. Fernández, Feng Hong and Scott H. Kaufmann.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026